Tennis: Swiatek Fails Doping Test, Accepts Suspension
Women’s tennis world number two and five-time Grand Slam champion, Iga Swiatek, has accepted a one-month suspension after testing positive for banned substance trimetazidine (TMZ), the International Tennis Integrity Agency said.
Swiatek tested positive in an out-of-competition sample in August but the ITIA, which runs tennis’s anti-doping programme, accepted that it was caused by contamination of her medication melatonin, which was manufactured and sold over the counter in her native Poland.
Swiatek said she had been taking it for jet lag and sleep issues and as there was no significant fault or negligence, the ITIA ruled it was “the lowest end of the range” and offered the reigning French Open champion a one-month suspension which the 23-year-old accepted.
Polish tennis player Iga Świątek has accepted a one-month suspension under the Tennis Anti-Doping Programme.
— International Tennis Integrity Agency (@itia_tennis) November 28, 2024
“The player was provisionally suspended from Sept. 12 until Oct. 4, missing three tournaments, which counts towards the sanction, leaving eight days remaining,” the ITIA said in a statement.”
She also forfeited prize money from the Cincinnati Open, the tournament directly following the test. Swiatek, who had pulled out of tournaments in Asia in September citing personal matters and fatigue, described the ordeal of testing positive as the “worst experience of my life”.
She was world number one when she failed the test and having skipped the Asian swing, Aryna Sabalenka leapfrogged her in the world rankings to eventually end the year as number one.
“In the last 2.5 months I was subject to strict ITIA proceedings, which confirmed my innocence,” Swiatek said on Instagram. “The only positive doping test in my career, showing unbelievably low level of a banned substance I’ve never heard about before, put everything I’ve worked so hard for my entire life into question.
“Both me and my team had to deal with tremendous stress and anxiety. Now everything has been carefully explained, and with a clean slate I can go back to what I love most.”
Swiatek, whose anti-doping violation was not made public at the time, had her provisional suspension lifted after providing samples of her melatonin product to the WADA-accredited SMRTL laboratory in Salt Lake City which confirmed detecting low doses of TMZ in both opened and sealed containers of the product.
The provisional suspension was lifted on Oct. 4 and the case forwarded to an Independent Tribunal.
Comments are closed.